Adjustments to surveillance practices in the EU will enhance preparedness and public health response to emerging infectious diseases, thereby helping to contain human and economic costs. These are the conclusions of an article published this week in Science magazine, describing a study co-authored by ECDC.
This study found a marked reduction in vaccine serotype carriage after PCV7 implementation. The overall pneumococcal, H. influenzae and S. aureus carriage decreased slightly, but not significantly.
The European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC) have published the second joint EU report on antimicrobial resistance in zoonotic bacteria affecting humans, animals and food.
The European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC) have published their annual report on zoonoses and food-borne outbreaks in the European Union for 2010.
This study demonstrates that PCV13 is immunogenic and safe in children previously vaccinated with PCV7. By eliciting high antibacterial immune responses to the additional serotypes, PCV13 provides protection against these serotypes, which are important causes of pneumococcal disease globally.
The evidence presented in the article strongly supports the notion that serotype replacement has occurred in invasive pneumococcal disease in most populations and is caused by the vaccine.
Marking World AIDS Day 2011, ECDC and the WHO Regional Office for Europe release today their joint publication HIV/AIDS surveillance in Europe 2010. The new data raises concern about the continuing transmission of HIV in Europe, as newly diagnosed HIV infections are still on the increase.
Universal screening of pregnant women is feasible and has led to immunisation in nearly all identified cases in Denmark. As a consequence of the study the National Board of Health has made universal HBsAg screening of pregnant women permanent in the country.
The chikungunya virus outbreak that occurred in 2007 in northern Italy (Emilia-Romagna region) prompted the development of a large scale monitoring system of the population density of Aedes albopictus (Skuse, 1894), comparable at the provincial and municipal levels. In 2007, egg density data presented an aggregated distribution (VMR >1) and Taylor's power law was applied to calculate the minimum number of ovitraps needed to obtain the prefixed precision levels: D=0.2 in the areas where the chikungunya epidemic occurred and D=0.3 in all the other urban areas >600 ha.
’Prevention of infections among people who inject drugs is achievable and effective – if it is properly executed’, stresses ECDC Director Marc Sprenger.